NeoCore Technology Co., Ltd. (4131.TWO)
TWD 31.95
(-10.0%)
TWD 31.95
(-10.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -196.39 Million TWD | -366.02% |
| 2022 | 73.82 Million TWD | -14.46% |
| 2021 | 86.31 Million TWD | 160.78% |
| 2020 | 33.09 Million TWD | 6.28% |
| 2019 | 31.14 Million TWD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -150.31 Million TWD | 12.47% |
| 2024 Q1 | -171.72 Million TWD | 12.56% |
| 2023 FY | -196.39 Million TWD | -366.02% |
| 2023 Q2 | -217.46 Million TWD | 8.59% |
| 2023 Q1 | -237.9 Million TWD | -427.39% |
| 2023 Q3 | -211.84 Million TWD | 2.58% |
| 2023 Q4 | -196.39 Million TWD | 7.29% |
| 2022 Q3 | 80.05 Million TWD | 0.0% |
| 2022 Q4 | 72.66 Million TWD | -9.23% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Anti-Microbial Savior BioteQ Co., Ltd | -77.04 Million TWD | -154.915% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | -264.16 Million TWD | 25.655% |
| Level Biotechnology Inc. | -453.9 Million TWD | 56.732% |
| Sagittarius Life Science Corp | -120.57 Million TWD | -62.89% |
| TaiMed Biologics Inc. | 499.84 Million TWD | 139.291% |
| GlycoNex Incorporation | -148.56 Million TWD | -32.194% |
| VBI | -25.31 Million TWD | -675.782% |
| GeneReach Biotechnology Corp. | 40.26 Million TWD | 587.749% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 137.99 Million TWD | 242.322% |
| SynCore Biotechnology Co.,Ltd | -262.58 Million TWD | 25.205% |
| Genomics BioSci & Tech. Co.,Ltd. | 30.57 Million TWD | 742.282% |
| Visgeneer Inc. | 31.28 Million TWD | 727.787% |
| Mycenax Biotech Inc. | 207 Million TWD | 194.874% |
| Sunmax Biotechnology Co., Ltd. | -680.6 Million TWD | 71.144% |
| G&E Herbal Biotechnology Co., Ltd. | -134.25 Million TWD | -46.29% |
| Neith Corporation | -150.31 Million TWD | -30.66% |
| Medigen Vaccine Biologics Corporation | 621.53 Million TWD | 131.599% |
| TaiwanJ Pharmaceuticals Co., Ltd. | -57.65 Million TWD | -240.624% |
| Enimmune corporation | -314.15 Million TWD | 37.485% |
| TaiRx, Inc. | -147.86 Million TWD | -32.818% |
| CHO Pharma, Inc. | -203.79 Million TWD | 3.629% |
| EirGenix Inc. | -4.58 Billion TWD | 95.719% |
| BioLASCO Taiwan Co., Ltd. | -84.76 Million TWD | -131.701% |
| Sunny Pharmtech Inc. | 120.87 Million TWD | 262.485% |
| Lin BioScience, Inc. | -3.21 Billion TWD | 93.897% |
| BioGend Therapeutics Co., Ltd. | -317.41 Million TWD | 38.127% |
| Feng Chi Biotech Corp. | -19.81 Million TWD | -891.253% |
| Bio Preventive Medicine Corp. | 31.8 Million TWD | 717.426% |
| Lukas Biomedical Inc. | 50.75 Million TWD | 486.951% |
| RBC Bioscience Corporation | 422.18 Million TWD | 146.519% |
| BiOptic Inc. | 12.59 Million TWD | 1659.697% |
| BRIM Biotechnology, Inc. | -944.4 Million TWD | 79.204% |
| Shine-On BioMedical Co.,Ltd. | -101.48 Million TWD | -93.521% |
| Great Novel Therapeutics Biotech & Medicals | -165.17 Million TWD | -18.902% |
| Syngen Biotech Co.,Ltd. | 314.87 Million TWD | 162.373% |
| Advagene Biopharma Co., Ltd. | -64.32 Million TWD | -205.339% |
| NaviFUS Corp. | -123.12 Million TWD | -59.505% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 74.05 Million TWD | 365.219% |
| Sinew Pharma Inc. | -160.34 Million TWD | -22.484% |
| Andros Pharmaceuticals Co.,Ltd | -241.89 Million TWD | 18.808% |
| Greenyn Biotechnology Co., Ltd | -337.37 Million TWD | 41.787% |
| Lumosa Therapeutics Co., Ltd. | -412.63 Million TWD | 52.405% |
| AP Biosciences Inc | -196.52 Million TWD | 0.067% |
| Medigen Biotechnology Corp. | 688.73 Million TWD | 128.516% |
| 3D Global Biotech Inc. | -11.43 Million TWD | -1617.207% |
| Pharmosa Biopharm Inc. | -829.69 Million TWD | 76.329% |
| Intech Biopharm Corporation | 1.35 Billion TWD | 114.469% |
| Oneness Biotech Co., Ltd. | -414.87 Million TWD | 52.662% |
| Eusol Biotech Co.,Ltd. | -209.33 Million TWD | 6.182% |
| TWi Biotechnology, Inc. | -143.86 Million TWD | -36.517% |
| Ever Supreme Bio Technology Co., Ltd | -330.54 Million TWD | 40.583% |
| TCI GENE Inc. | -689.25 Million TWD | 71.506% |
| MegaPro Biomedical Co., Ltd | -118.93 Million TWD | -65.126% |
| Senhwa Biosciences, Inc. | -1.3 Billion TWD | 84.999% |
| Taiwan Bio Therapeutics Co., Ltd | 20.48 Million TWD | 1058.829% |
| NatureWise Biotech & Medicals Corporation | -101.87 Million TWD | -92.792% |
| PharmaEngine, Inc. | -860.8 Million TWD | 77.185% |
| Savior Lifetec Corporation | -812.54 Million TWD | 75.829% |
| TaiGen Biopharmaceuticals Holdings Limited | -299.96 Million TWD | 34.527% |
| OBI Pharma, Inc. | -398.22 Million TWD | 50.682% |
| Meribank Biotech Co., Ltd | -365.41 Million TWD | 46.254% |
| Acepodia, Inc. | -6.02 Billion TWD | 96.738% |
| Caliway Biopharmaceuticals Co., Ltd. | -3.4 Billion TWD | 94.226% |